Cardiovasc Res 54(3):516527 Menegola E, Di Renzo F, Broccia ML, Giavini E (2006) Inhibition of histone deacetylase as a new mechanism of teratogenesis
Their broad metabolic effects make them valuable tools for tackling complex metabolic syndromes
Comprehensive real-world assessment of marketed medications to guide Parkinsons drug discovery
Electronic supplementary material ESM Downloadable slide (download PPTX (PPTX 145 kb) Rights and permissions Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
In an analysis of patient records tracked by Epic Research, over 400,000 patients treated with GLP-1 agonists for one year at peak doses for diabetes or weight loss, liraglutide was the least effective (Bartelt K et al, Epic Research